Catalyst Wire Dossier Catalyst Wire Dossier

Rebif

interferon beta-1a · Merck Europe B.V.
Drug timelines are a Plus or Pro feature.

68 regulatory and trial events tracked for Rebif, covering 2009-06-05 to 2026-04-08. Get the full timeline:

Most recent: EMA Authorised: Rebif (interferon beta-1a) — Merck Europe B.V.

See pricing